The flexibility and scalability of our Olink® Explore platform can be utilized either for full-scale screening of our entire library of 3072 assays, or in studies that focus on one or several of the eight Explore 384-plex panels that make up the Explore 3072 library.
This panel contains assays related to cardiovascular and metabolic pathways and processes, as well as other proteins that can be considered as more exploratory biomarkers. The majority of the assays in our Olink® Target 96 Cardiovascular II, Cardiovascular III, Metabolic, and Cardiometabolic panels are included in the Explore 384 Cardiovascular panel.
The Explore 384 Cardiometabolic and Cardiometabolic II panels offer simultaneous analysis of 384 of these protein biomarkers using just 1 µL of biological sample. All assays are subject to Olink’s strict technical validation and Quality Control procedures.
The assays in different Explore 384 panels are divided into different probe pools, called blocks, with different sample dilution factors to ensure optimal read-out quality.
| The Cardiometabolic panel › | 1:1 | 1:10 | 1:100 | 1:1000 | |
| The Cardiometabolic II panel › | 1:1 | 1:10 | 1:100 |
Note that relevant cardiovascular biomarkers can also be placed in other Explore 384 panels for optimal readout quality.
Our technical validation of assays are performed in vitro using recombinant analytes. All technical validation data reported on the biomarker pages are based on these in vitro assays.
2947
Biomarker assays
~881 million
Protein data points generated
886
Publications listed on website